|
Market Closed -
Nasdaq
16:00:00 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 31.34 USD | -0.25% |
|
+7.11% | +1.75% |
| 08-12 | BNP Paribas Initiates Genmab at Outperform, With $40 Price Target | MT |
| 08-12 | Nordic stocks in North America: AstraZeneca fell 1.0% | FW |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 1.38% | 1.58% | 20.94x | 4.9x | 7.34x | 14.96x | 16.92x | 70.1B | ||
| 0.05% | 0.09% | 31.3x | 6.22x | 7.97x | 24.33x | 24.86x | 54.93B | ||
| -.--% | -.--% | -86.53x | 40.52x | 15.66x | -79.82x | -97.56x | 28.89B | ||
| -.--% | -.--% | 30.32x | 2.92x | 5.94x | 15.72x | 18.91x | 23.9B | ||
| -.--% | -.--% | -14.59x | 1.15x | 5.14x | -6.7x | -5.29x | 23.3B | ||
| 0.07% | 0.1% | 55.29x | 14.18x | 22.62x | 58.25x | 53.44x | 18.41B | ||
| -.--% | -.--% | 25.72x | 3.07x | 4.87x | 16.34x | 18.37x | 18.77B | ||
| -.--% | -.--% | -1224.8x | 19.38x | 38.27x | -15166.74x | -554.3x | 16.1B | ||
| -.--% | -.--% | 15.63x | 4.79x | 4.6x | 10.74x | 11.46x | 12.48B | ||
| -.--% | -.--% | -24.59x | 31.64x | 24.84x | -27.67x | -24.82x | 12.32B | ||
| -.--% | -.--% | -84.92x | 27.6x | 7.77x | -64.38x | -63.01x | 12.39B | ||
| -.--% | -.--% | -13.74x | 44.19x | 2884.91x | -14.77x | -12.68x | 12.05B | ||
| -.--% | 0.02% | -1376.3x | 8.57x | 15.25x | 116.66x | 720.51x | 11.98B | ||
| -.--% | -.--% | -12.36x | -60.93x | 62.31x | -13.02x | -12.78x | 10.52B | ||
| -.--% | -.--% | 11.51x | 5.8x | 8.23x | 13.3x | 14.07x | 8.99B | ||
| -.--% | -.--% | -36.29x | 9.35x | - | -32.3x | -33.04x | 9.18B | ||
| -.--% | -.--% | -7.12x | - | - | -7.37x | -6.82x | 8.88B | ||
| Average | 0.09% | 0.11% | -158.27x | 10.21x | 207.71x | -890.73x | 4.01x | 20.77B | |
| Weighted average by Cap. | 0.28% | 0.33% | -100.19x | 10.19x | 116.12x | -687.01x | -1.03x |
- Stock Market
- Stocks
- GMAB Stock
- GMAB Stock
- Sector Genmab A/S
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















